Today, they support customers worldwide – always with sustainability in mind. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services for fertility clinics, founded in 2011. Together they create Vitrolife Group, a global leader in reproductive health.
By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, they support clinics and patients across the fertility journey. Based on science and advanced research capabilities, thier aim is to deliver products and services for the entire fertility journey, providing consistent performance and guaranteed quality.
They are a sustainable market leader and aim to be the preferred partner to the fertility clinics by providing superior products and services. Currently, Vitrolife Group are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Their products and services are available in more than 110 countries, through their own presence in 30 countries, and a network of distributors.